Inkampani yaseCupertino ayipheli ezingxoxweni nezinye izinkampani emkhakheni wezokwelapha nowezempilo. Esimweni esinjalo I-COO ka-Apple uqobo, uJeff Williams, ubephethe ukumemezela ukusebenzisana nenkampani yeJNJ kaJohnson & Johnson, iJanssen Pharmaceuticals, enezinhlangothi eziningi ezivulekile zokuthuthukisa impilo yabantu.
Kulokhu, kuyisicelo esihlobene nempilo yenhliziyo, esenze i-Apple yabanaka futhi ngaleyo ndlela yakha ubudlelwane phakathi kwalezi zinkampani ezimbili. Empeleni, kunenkulumo yokusebenzisa i-Apple Watch nalolu hlelo lokusebenza ukusheshisa ukuxilonga nokwenza ngcono imiphumela yokuhlolwa kwabantu abane-atrial fibrillation.
UJNJ kaJohnson & Johnson, Inkampani Janssen Pharmaceuticals Inc. Ujoyina iqembu elisebenza ne-Apple kwezempilo futhi akulona elokuqala kodwa ngeke kube elokugcina. Ezikhathini zakamuva i-Apple ibambe iqhaza ngokuphelele kwezempilo futhi leli ibhizinisi elihle ezinkampanini zobuchwepheshe ezifana ne-Apple ezibona umthambo omuhle wamahhala wokuphenya nokusebenza.
Ngewashi le-Apple esihlakaleni kubonakala sengathi umsebenzi ophambili walolu hlelo kanye nalo lonke ucwaningo luzogxila ekutholeni nasekutholakaleni kwe-AFIB kusenesikhathi. Kulokhu kuhle ukusho ukuthi i-atrial fibrillation yisimo sokuthi kuthinta abantu abayizigidi ezingama-33 emhlabeni jikelele futhi izimo zivame ukuba amahlule egazi, ukushaywa unhlangothi, nokuhluleka kwenhliziyo. Okwamanje, futhi kungenziwa kanjani ngenye indlela, ucwaningo nentuthuko luzokwenziwa kuphela (okungenani okwamanje) e-US futhi abantu okulindeleke ukuthi basebenze nabo kumele babe phakathi kweminyaka engama-65 ubudala. Noma ngaphezulu.
